Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Denison Mines NYSEAMERICAN:DNN$1.81 +0.02 (+1.12%) Closing price 02/7/2025 04:10 PM EasternExtended Trading$1.82 +0.01 (+0.55%) As of 08:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.60 billionConsensus RatingStrong BuyConsensus Price Target$3.00 (+65.7% Upside)Volume49.90 million sharesAverage Volume35.77 million sharesToday's Range $1.79 ▼ $1.86 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Quince Therapeutics NASDAQ:QNCX$1.48 -0.10 (-6.33%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.52 +0.04 (+3.04%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$69.52 millionConsensus RatingBuyConsensus Price Target$9.50 (+541.9% Upside)Volume347,655 sharesAverage Volume126,175 sharesToday's Range $1.43 ▼ $1.60 3. GeoVax Labs NASDAQ:GOVX$1.70 -0.01 (-0.58%) As of 02/7/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$16.14 millionConsensus RatingBuyConsensus Price Target$14.20 (+735.3% Upside)Volume386,120 sharesAverage Volume584,823 sharesToday's Range $1.67 ▼ $1.76 4. Cardiol Therapeutics NASDAQ:CRDL$1.35 -0.10 (-6.90%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.42 +0.06 (+4.81%) As of 08:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$119.78 millionConsensus RatingBuyConsensus Price Target$8.40 (+522.2% Upside)Volume295,052 sharesAverage Volume244,533 sharesToday's Range $1.31 ▼ $1.49 5. Immunic NASDAQ:IMUX$0.96 -0.02 (-1.98%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.98 +0.02 (+2.53%) As of 08:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$88.29 millionP/E Ratio-0.78Consensus RatingBuyConsensus Price Target$12.67 (+1,218.5% Upside)Volume424,888 sharesAverage Volume992,769 shares6. Western Copper & Gold NYSE:WRN$1.09 0.00 (0.00%) As of 02/7/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$216.25 millionConsensus RatingBuyConsensus Price Target$4.25 (+289.9% Upside)Volume239,070 sharesAverage Volume261,528 sharesToday's Range $1.07 ▼ $1.13 7. FibroBiologics NASDAQ:FBLG$1.86 +0.26 (+16.25%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.89 +0.03 (+1.40%) As of 08:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$58.25 millionConsensus RatingBuyConsensus Price Target$13.00 (+598.9% Upside)Volume2.27 million sharesAverage Volume208,281 sharesToday's Range $1.75 ▼ $2.00 8. Lucid Diagnostics NASDAQ:LUCD$1.07 +0.10 (+10.56%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.09 +0.02 (+1.87%) As of 08:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$57.43 millionConsensus RatingBuyConsensus Price Target$3.63 (+238.8% Upside)Volume781,608 sharesAverage Volume194,222 sharesToday's Range $0.95 ▼ $1.07 9. PMV Pharmaceuticals NASDAQ:PMVP$1.44 +0.01 (+0.70%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.45 +0.01 (+0.69%) As of 07:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV PharmaceuticalsMarket Capitalization$74 millionConsensus RatingBuyConsensus Price Target$5.50 (+281.9% Upside)Volume137,918 sharesAverage Volume151,108 sharesToday's Range $1.42 ▼ $1.44 10. Unicycive Therapeutics NASDAQ:UNCY$0.57 -0.04 (-7.13%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.57 +0.00 (+0.78%) As of 08:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Unicycive Therapeutics, Inc, a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. More about Unicycive TherapeuticsMarket Capitalization$63.21 millionConsensus RatingBuyConsensus Price Target$5.50 (+872.4% Upside)Volume691,045 sharesAverage Volume955,472 sharesToday's Range $0.56 ▼ $0.61 11. Rani Therapeutics NASDAQ:RANI$1.52 -0.13 (-7.88%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.46 -0.06 (-4.28%) As of 08:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani TherapeuticsMarket Capitalization$94.53 millionConsensus RatingBuyConsensus Price Target$12.33 (+711.4% Upside)Volume2.17 million sharesAverage Volume1.92 million sharesToday's Range $1.50 ▼ $1.65 12. Context Therapeutics NASDAQ:CNTX$0.87 -0.02 (-2.57%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.90 +0.03 (+3.64%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$67.21 millionConsensus RatingBuyConsensus Price Target$6.33 (+625.3% Upside)Volume86,101 sharesAverage Volume206,134 sharesToday's Range $0.85 ▼ $0.94 13. Tenaya Therapeutics NASDAQ:TNYA$0.96 -0.04 (-3.55%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.99 +0.03 (+2.64%) As of 08:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya TherapeuticsMarket Capitalization$79.22 millionConsensus RatingBuyConsensus Price Target$17.33 (+1,697.1% Upside)Volume2.19 million sharesAverage Volume1.73 million sharesToday's Range $0.95 ▼ $1.07 14. Biodesix NASDAQ:BDSX$1.00 -0.04 (-3.85%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.00 0.00 (0.00%) As of 08:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biodesix, Inc operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. More about BiodesixMarket Capitalization$151.29 millionConsensus RatingBuyConsensus Price Target$3.06 (+206.0% Upside)Volume239,585 sharesAverage Volume496,630 sharesToday's Range $0.99 ▼ $1.03 15. Clearside Biomedical NASDAQ:CLSD$1.13 +0.06 (+5.61%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.07 -0.06 (-5.22%) As of 08:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clearside Biomedical, Inc, a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. More about Clearside BiomedicalMarket Capitalization$81.15 millionConsensus RatingBuyConsensus Price Target$5.33 (+372.0% Upside)Volume347,017 sharesAverage Volume153,561 sharesToday's Range $1.06 ▼ $1.14 16. Gossamer Bio NASDAQ:GOSS$1.06 -0.05 (-4.50%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.06 0.00 (0.00%) As of 08:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gossamer Bio, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. More about Gossamer BioMarket Capitalization$251.53 millionConsensus RatingBuyConsensus Price Target$9.20 (+767.9% Upside)Volume693,316 sharesAverage Volume875,129 sharesToday's Range $1.02 ▼ $1.09 17. Inozyme Pharma NASDAQ:INZY$1.45 -0.05 (-3.33%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.48 +0.03 (+1.72%) As of 08:54 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inozyme Pharma, Inc, a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. More about Inozyme PharmaMarket Capitalization$96.36 millionConsensus RatingBuyConsensus Price Target$18.33 (+1,164.4% Upside)Volume405,167 sharesAverage Volume1.02 million sharesToday's Range $1.44 ▼ $1.52 18. Caribou Biosciences NASDAQ:CRBU$1.35 -0.07 (-4.93%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.40 +0.05 (+4.07%) As of 08:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Caribou Biosciences, Inc, a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. More about Caribou BiosciencesMarket Capitalization$128.59 millionConsensus RatingBuyConsensus Price Target$10.33 (+665.4% Upside)Volume680,953 sharesAverage Volume1.51 million sharesToday's Range $1.35 ▼ $1.42 19. Cue Biopharma NASDAQ:CUE$1.28 -0.07 (-5.19%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.23 -0.05 (-3.98%) As of 08:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cue Biopharma, Inc, a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. More about Cue BiopharmaMarket Capitalization$85.52 millionConsensus RatingBuyConsensus Price Target$5.00 (+290.6% Upside)Volume380,007 sharesAverage Volume266,150 sharesToday's Range $1.20 ▼ $1.38 20. Elevation Oncology NASDAQ:ELEV$0.63 -0.04 (-5.85%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.64 +0.01 (+1.41%) As of 08:56 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Elevation Oncology, Inc, an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. More about Elevation OncologyMarket Capitalization$39.63 millionConsensus RatingBuyConsensus Price Target$7.20 (+1,040.9% Upside)Volume1.22 million sharesAverage Volume3.89 million sharesToday's Range $0.62 ▼ $0.68 21. Cognition Therapeutics NASDAQ:CGTX$0.64 0.00 (-0.77%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.63 0.00 (-0.63%) As of 08:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cognition Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. More about Cognition TherapeuticsMarket Capitalization$26.59 millionP/E Ratio-0.65Consensus RatingBuyConsensus Price Target$8.30 (+1,207.1% Upside)Volume298,129 sharesAverage Volume876,450 shares22. Ovid Therapeutics NASDAQ:OVID$0.67 -0.03 (-3.87%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.68 +0.01 (+1.49%) As of 08:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$49.49 millionConsensus RatingBuyConsensus Price Target$4.03 (+502.0% Upside)Volume187,999 sharesAverage Volume544,787 sharesToday's Range $0.67 ▼ $0.71 23. Century Therapeutics NASDAQ:IPSC$0.73 -0.04 (-4.92%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.77 +0.04 (+5.73%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Century Therapeutics, Inc, a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. More about Century TherapeuticsMarket Capitalization$64.87 millionConsensus RatingBuyConsensus Price Target$10.00 (+1,278.5% Upside)Volume516,676 sharesAverage Volume479,856 sharesToday's Range $0.72 ▼ $0.78 24. Beyond Air NASDAQ:XAIR$0.42 +0.02 (+3.85%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$0.44 +0.03 (+6.40%) As of 09:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. More about Beyond AirMarket Capitalization$31.58 millionP/E Ratio-0.29Consensus RatingBuyConsensus Price Target$3.67 (+782.7% Upside)Volume1.32 million sharesAverage Volume1.03 million shares25. Taysha Gene Therapies NASDAQ:TSHA$1.75 +0.09 (+5.42%) Closing price 02/7/2025 04:00 PM EasternExtended Trading$1.77 +0.02 (+1.14%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Taysha Gene Therapies, Inc, a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. More about Taysha Gene TherapiesMarket Capitalization$340.21 millionP/E Ratio2.78Consensus RatingBuyConsensus Price Target$6.63 (+278.6% Upside)Volume3.24 million sharesAverage Volume2.06 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst? Why Waste Management Stock Is a Top Defensive Play Now Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? IBM’s AI Bet Pays Off—What’s Next for Investors? Meta Platforms Continues to Prove Why It's a Premier Play on AI Broadcom's Bull Run: Time to Jump In? Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity? Price Plunge in Roblox Presents Opportunity for Robust Gains Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
